Back to Search
MARK KIERAN, MD PHD
MD PHD
Pediatric Hematology & Oncology Physician
NPI: 1790747236Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
76146(MA)
Research & Publications (20)
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.
PMID 19065567·Pediatr Blood Cancer·2009
3-trial
Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study.
PMID 17634493·J Clin Oncol·2007
3-trial
A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer.
PMID 16282886·J Pediatr Hematol Oncol·2005
3-trial
Anti-angiogenic chemotherapy in central nervous system tumors.
PMID 15015568·Cancer Treat Res·2004
6-review
Antiangiogenesis therapy. Current and future agents.
PMID 11765376·Hematol Oncol Clin North Am·2001
6-review
Small molecule inhibitors in children with malignant gliomas.
PMID 19434732·Pediatr Blood Cancer·2009
6-review
Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells.
PMID 18682579·Neuro Oncol·2009
7-preclinical
Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor.
PMID 19064966·J Clin Oncol·2009
4-observational
A prospective, blinded analysis of A-PROTEIN (recoverin or CAR protein) levels in pediatric patients with central nervous system tumors.
PMID 19422022·Pediatr Blood Cancer·2009
8-other
Medical, psychological, cognitive and educational late-effects in pediatric low-grade glioma survivors treated with surgery only.
PMID 19479971·Pediatr Blood Cancer·2009
8-other
Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.
PMID 19548852·Expert Opin Investig Drugs·2009
6-review
Molecular aspects, clinical aspects and possible treatment modalities for Costello syndrome: Proceedings from the 1st International Costello Syndrome Research Symposium 2007.
PMID 18412122·Am J Med Genet A·2008
8-other
Outcome of pediatric pineoblastoma after surgery, radiation and chemotherapy.
PMID 18415046·J Neurooncol·2008
8-other
Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth.
PMID 18222970·Exp Biol Med (Maywood)·2008
7-preclinical
Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas.
PMID 18716553·J Neuropathol Exp Neurol·2008
8-other
PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.
PMID 18199835·Proc Natl Acad Sci U S A·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY ST, ROOM SW331
BOSTON, MA 02115 - Phone
- (617) 632-4907
Quick Facts
- NPI
- 1790747236
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile